CLINICAL_TRIALS
trial_result
· 2024-05-30
Clinical Trial Update: A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM) [Phase 1]
Summary
This update reports the completion of a Phase 1 study of LY3549492 in adults with Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED